Skip to main content

Table 2 Summary of CARM1 genetic alteration and clinical survival prognosis in various cancers cases

From: Systematic pan-cancer landscape identifies CARM1 as a potential prognostic and immunological biomarker

Tumor types

Sample size

P

OS

PFS

DSS

DFS

BLCA

562

0.743

NA

NA

0.0465

BRCA

963

0.793

NA

NA

0.469

CESC

278

0.883

0.0239

0.87

0.00003

COAD

436

0.521

0.0202

0.845

0.0314

SKCM

363

0.077

0.191

0.145

NA

GBM

378

0.356

0.501

0.273

NA

HNSC

385

0.0012

NA

NA

NA

LUAD

230

0.334

NA

NA

0.055

LUSC

469

0.62

0.44

0.263

0.583

PRAD

489

0.515

0.29

0.667

0.0432

STAD

434

0.0315

0.277

0.132

0.448

UCS

509

0.535

0.147

0.298

0.263

  1. P value derived from Log Rank test. The bold font indicates that the prognosis of the mutated group is worse than that of the non-mutated group. NS, P > 0.05; * P < 0.05; ** P < 0.01; *** P < 0.001
Back to article page

BMC Genomic Data

ISSN: 2730-6844

Contact us